Evidence map›Paper›PMID 36795617›Full record

ReviewZebrafish2023

Caroline Caetano da Silva, Agnes Ostertag, Ratish Raman, Marc Muller, Martine Cohen-Solal, Corinne Collet

Open access · hybridAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Zebrafish, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 3 countries.

Caroline Caetano da SilvaINSERM U1132 and Université Paris-Cité, Reference Centre for Rare Bone Diseases, Hospital Lariboisière, Paris, France.
Agnes OstertagINSERM U1132 and Université Paris-Cité, Reference Centre for Rare Bone Diseases, Hospital Lariboisière, Paris, France.
Ratish RamanLaboratory for Organogenesis and Regeneration (LOR), GIGA-Research, Liège University, Liège, Belgium.
Marc MullerLaboratory for Organogenesis and Regeneration (LOR), GIGA-Research, Liège University, Liège, Belgium.
Martine Cohen-SolalINSERM U1132 and Université Paris-Cité, Reference Centre for Rare Bone Diseases, Hospital Lariboisière, Paris, France.
Corinne ColletINSERM U1132 and Université Paris-Cité, Reference Centre for Rare Bone Diseases, Hospital Lariboisière, Paris, France.
Inserm · FRUniversity of Liège · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Wnt signaling is a key regulator of osteoblast differentiation and mineralization in humans and animals, mediated by the canonical Wnt/β-catenin and noncanonical signaling pathways. Both pathways are crucial in regulating osteoblastogenesis and bone formation. The zebrafish silberblick (

Indexed as

OsteogenesisZebrafishAnimalsCell DifferentiationHumansModels, AnimalSignal TransductionWnt Signaling PathwayZebrafish ProteinsZebrafish Proteinsdevelopmenthigh bone masswnt11f2Wnt pathwayszebrafish

Identifiers

PMID36795617
PMCPMC9968865
OpenAlexW4321003258

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.